Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Education program aims to cut stroke recurrence in bangladesh

NCT ID NCT05520034

Disease control Sponsor: Hiroshima University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests whether a nurse-led health education program for first-time stroke patients and their family caregivers can lower the chance of having another stroke. The program includes face-to-face sessions, phone reminders, and tools like a blood pressure machine and salt spoon. Researchers will compare the stroke recurrence rate between 432 patients who get the education and those who do not.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
health education program
What this could lead to
If successful, this could show that simple education and monitoring help stroke patients avoid another stroke.
What could go wrong
This is a single-center trial in Bangladesh, so results may not apply everywhere. Education alone may not be enough to change long-term habits.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 432 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2022

Expected to finish

Mar 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

For patient 1. Who was discharged from NINSH to home or who visited NINSH right after getting a stroke 2. First-time stroke 3. All types of strokes, except subarachnoid haemorrhage 4. modified Rankin Scale (0 - 4) 5. Stroke patient who is 18 years old and above 6. Both males \& females 7. Who provided written consent \& willing to participate in the study For family caregivers 1. Primary caregivers irrespective of sex and aged 18 years old and above, living with the patient who take care of an above patient and who meets all of the inclusion criteria (will be decided by one person) 2. Who will provide written consent \& willing to participate in the study Exclusion Criteria: Exclusion criteria of patient 1. Who has stroke with the recurrence 2. Stroke subtype: caused by genetic problems or injury/accident 3. Patients with multi-organ failure or terminal stage 4. Participation in other clinical trials 5. Unwillingness to participate in the study 6. Not having a mobile phone at home 7. mRS 5 Exclusion criteria of caregiver 1. Who is not living with the patient 2. Who is under 18 years old 3. Who is mentally unstable and/or cognitively impaired (diagnosed cases)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Stroke are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Health Education stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Stroke

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • National Institute of Neurosciences & Hospital

    RECRUITING

    Dhaka, 1207, Bangladesh

More trials for these conditions

Other studies related to the condition(s) this trial covers.